Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The fickle finger of fate
Luis de la Fuente, Jill A. Helms
Luis de la Fuente, Jill A. Helms
Published April 1, 2005
Citation Information: J Clin Invest. 2005;115(4):833-836. https://doi.org/10.1172/JCI24840.
View: Text | PDF
Commentary

The fickle finger of fate

  • Text
  • PDF
Abstract

In this issue of the JCI, Niedermaier and colleagues demonstrate that a chromosomal inversion in mice results in dysregulation of Sonic hedgehog (Shh), such that Shh is ectopically expressed in a skeletogenic domain typically occupied by Indian hedgehog (Ihh). This molecular reversal eliminates phalangeal joint spaces, and consequently, Short digits (Dsh) heterozygotes (Dsh/+) have brachydactyly (shortened digits). Ihh is normally downregulated in regions that will become the joint space, but in Dsh/+ mice, Shh bypasses this regulatory control and persists; accordingly, cells maintain their chondrogenic fate and the developed digits are shorter than normal. The significance of these data extends far beyond the field of skeletal biology: they hint at the very real possibility that the endogenous Shh regulatory region contains a repressor designed to segregate the activity of Shh from Ihh. The existence of such a repressor provides a window into the distant past, revealing that Shh and Ihh must once have shared responsibilities in establishing tissue boundaries and orchestrating vertebrate tissue morphogenesis.

Authors

Luis de la Fuente, Jill A. Helms

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Disrupted expression boundaries in Dsh/+ animals lead to perichondrial a...
Disrupted expression boundaries in Dsh/+ animals lead to perichondrial and joint defects (1). A transverse schematic of the phalangeal skeletal condensation, showing expression domains corresponding to a specific Hedgehog gene (Ihh in WT, Shh in Dsh/+), the Hedgehog target Ptch, and the Hedgehog repressor Gli3. Dotted lines indicate the normal cartilage-perichondrium boundary. In WT phalanges, Ihh (purple) is initially expressed (E12.5) in a small domain that expands over time to encompass the skeletal condensation. At E12.5 in Dsh/+ phalanges, Shh expression (blue) encompasses the normal Ihh domain and over time extends beyond what would normally be the cartilage-perichondrium boundary. Ptch (orange), an indicator of Hedgehog responsiveness, is first expressed in WT phalanges coincident with Ihh; eventually, Ptch is downregulated in cells expressing Ihh and upregulated in cells adjacent to the Ihh domain, where it functions to limit the spread of Hedgehog expression. Note the absence of color within the element, which shows the relative lack of Ptch in this domain (10). In Dsh/+ phalanges, Ptch is expressed coincident with the broader domain of Shh; however, in contrast to what occurs in WT tissues, Ptch does not become downregulated in chondrocytes. Gli3 (green), a repressor of Hedgehog signaling, is initially expressed in WT phalanges in a domain overlapping with Ihh; over time, this domain is restricted to the perichondrium, where Gli3 limits the activity of the Hedgehog protein. In Dsh/+ phalanges the Gli3 expression domain is initially broader, and only after an extended period of time does it become restricted to the perichondrium.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts